Trading Summary - November 22. No change in the OTC

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
158
Trading Summary - November 22.

No change in the OTC market generally today. The majority of the OTC market is either at a standstill or crashing at present as legacy convertible debt holders ramp up their conversions. Many companies amateurs are chasing have an A/S of 10B / 20B now and an O/S that is a significant portion of that. Whereas many .0005 > .0010 tickers have crashed through multiple price points with 100M+ on each over the past few days, $SFLM remains stable and continues to attract new interest.

On $SFLM, those who already have sufficient shares in the bottom .0025 > .0052 range for trading ahead were looking for bargains elsewhere for much of the day while also countering the usual games from the scammer by making buys up to 400K at a time on undercut asks at .0026 > .0027.

Overall on $SFLM, longs (including me) and new interest bought another 1.7M shares at bottom prices in the same broad range under .0052.

Since the loading at bottom prices total was restarted after the last run, 485.1M shares have been bought up to .0052 in 44 trading days September 22 - November 22 - 58% of the low Unrestricted Outstanding Shares count.

New interest traders / alerters + long-term traders with significant followings as at November 21 numbered at least 116 - up 5 in the previous 7 days. List here:

https://investorshangout.com/post/view?id=6287525

Particular points they like are:

- Real revenue of $9.907M > $10M+ per year.

- Operating profit achieved in Q3.

- $49K in cash available for inventory purchases.

- Assets of $1.398M

- Low Unrestricted O/S of 837M - with none added on the latest monthly update.

- How thin it is into the .01 > .02 range.

On the next run over .01, the degree to which $SFLM penetrates up towards .02+ will depend on how many of these new followers take profits above .01.

Either way, longs who follow my strategy will be keeping their core holding for the OTCQB uplisting - which will require sustaining prices above a .01 bid - and also some for when all 9 elements reach the same revenue level anticipated by the CEO. Trading some on every surge allows a larger core to be held on a cost basis that is essentially "free" - already paid for by banked profits.

The correct market cap price for the anticipated revenue as income ramps up under the Collectibles Marketplace Strategy would be in the .062 > .1075 range in future years when they manage to get all 9 elements in the plan to the performance level of the existing SFLMaven eBay business (plus remember more platforms coming as well).

On $SFLM, the larger the inventory of shares acquired below .0050, the more that will be available to trade for 100% to 400% in the .01 > .0150 range on the next run to that level - whenever that may be - whilst also retaining a significant core converted to free for OTCQB uplisting and the planned 8 x 2021 revenue under the Collectibles Marketplace Strategy.

Remember that the price difference between .0030 and .0050 is irrelevant when traded at .01 > .02+ - let alone at .062 > .1075.

Every 1M bought at .0030 is worth a $7K profit at .01, $10K profit at .0130 and $17K profit at .02.

Every 1M bought at .0050 is worth a $7K profit at .0120, $10K profit at .0150 and $15K profit at .02.

Every 1M bought at .0050 is worth a $57K profit at .074 or $102.5K profit at .1075.

All that matters is who got where - charts are irrelevant - and denying as many shares under .01 as possible to the institutional level new interest that PRs + improving financials + MZ Group though investor symposiums are expected to bring in over the days, weeks and months ahead.

Latest DD - updated November 21 - here:

https://investorshangout.com/post/view?id=6287542

The anticipated revenue in 2021 - based on pro-rata of sales to date - is $ 9.907M > $10M+.

Additional inventory on the 1stDibs store at "BuyItNow" prices total of $332K.

$SFLM remains my #1 Top Profit Pick for the whole of 2021 and for me is currently #2 - flip flopping #1 - behind only $ENZC - due to the regular periodic surges.

It will now also be the #1 or #2 Top Profit Pick for the whole of 2022 (depending on $ENZC developments in the next 2 months).

I will not necessarily be doing a trading summary every day - unless there are undue manipulation attempts - as the ticker is firmly under control and just awaiting the next run into the .01 > .02 range.

iHub has been deliberated marginalized due to time-wasting nonsense there with all serious interest successfully directed to here over the last several months - with typically 500 > 700+ views per day - and repeated where interest in "real" companies is known to exist.

Nationwide expansion of the NFT Division continued on October 19 with the sign-up of a second regional based artist.

Also bear in mind that Q4 is traditionally the best Q each year due to Christmas shopping and supply chain issues in brick and mortar stores forcing more people to consider on-line purchases in good time.

The 2021 Q3 was filed after the close on November 15 - it was in line with the expectations of the top trader close followers of $SFLM with increased sales, increased gross profit, increased assets and vastly increased cash available for inventory purchase. Most importantly, the cash flow actually flipped positive for the first time ever - in Q3 rather than Q4 - where Q4 will obviuosly be even better than Q3.

2021 Q3 Key Points here:

https://investorshangout.com/post/view?id=6283945

We may see a PR soon on the excellent performance in Q3.



SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Study Exposes Grim Reality for Moderate Aortic Stenosis

Updated Category News Views 86

Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...

Continue Reading
MemorialCare Expands Cutting-Edge GERD Treatment Options

Updated Category News Views 95

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

Continue Reading
Envision's 800V DC System Cuts the Powercake First

Updated Category News Views 70

Envision Hits a Milestone in AI Power Dynamics You ever feel like the future is knocking on your door, but you've still got your headphones on? Well, Envision just kicked the door open with the world's first commercial deployment of an integrated 800-volt direct current (800V DC) power system in a large-scale AI data center. This technological marvel is now up and running...

Continue Reading
Watches of Switzerland Dazzles with Holiday Campaign

Updated Category News Views 84

Swiss Timepieces Take Center Stage Ever feel like there's a certain art to gift-giving? Apparently, The Watches of Switzerland Group thinks so, and they're not holding back in showing us how it's done with their new 'Brilliantly Given' campaign. They’re taking a classic approach by spotlighting luxury timepieces and fine jewelry just in time for the holiday...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 22

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
Gamehaus Expands with Anamana AI-Driven Acquisition

Updated Category News Views 127

Gamehaus Moves Deep Into AI Waters Sailing right into a new frontier, Gamehaus is all set to splash $19.6 million for a hefty slice of Techforge, the parent of the AI-powered Anamana. Gamehaus: a game publisher taking aim at becoming an AI content giant. You might ask yourself, "Can they pull it off?" Well, that's what I'm pondering over my lukewarm coffee today....

Continue Reading
Muyang Group's High-Stakes Legal Battle Over Corporate Sabotage

Updated Category News Views 139

Decades of Corporate Drama Unfold in Court A pesky legal storm is brewing from the heart of Yangzhou, China, as Jiangsu Muyang Group battles former execs in a lawsuit that reeks of corporate intrigue. You can't make this stuff up—downright Shakespearean treachery unfolding at a feed machinery powerhouse! Muyang's courtroom escapades haven't exactly flown under the...

Continue Reading
Yuhang's Innovative Tech: Journalists Get A Front Row Seat

Updated Category News Views 78

A Sneak Peek into Yuhang's Technological Leap Imagine strolling through a place where technology and nature coexist in harmony. That's exactly what journalists from around the globe got to experience during their recent jaunt to Yuhang District in Hangzhou. We're talking about reps from South Korea, Turkey, the U.S., and even Cuba getting a firsthand look at Yuhang's...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 29

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 84

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Upgrades Roku's Price Target, Highlighting Profitability Potential

Updated Category News Views 133

Citi Increases Price Target for Roku, Enhancing Investor Confidence Recently, Citi raised its price target for Roku (NASDAQ: ROKU) shares from $60 to $77. This change indicates the bank's increased confidence in Roku's potential to boost its platform revenue growth through a range of initiatives. Despite this upward adjustment, Citi has maintained a Neutral rating on the...

Continue Reading
Elon Musk Expresses Frustration Over FEMA Aid Delay for Starlink

Updated Category News Views 310

Elon Musk's Battle for Hurricane Aid Elon Musk, the influential CEO of Tesla and SpaceX, recently voiced his strong concerns regarding the delivery of Starlink terminals and other essential supplies to regions affected by Hurricane Helene. His determination to aid disaster relief efforts was met with unexpected hurdles, notably an initial refusal from the Federal...

Continue Reading
Easy Environmental Solutions to Transform Agriculture in Africa

Updated Category News Views 257

Easy Environmental Solutions Makes Major Progress Towards African Expansion Easy Environmental Solutions Inc., previously known as Digital Utilities Ventures Inc. and listed under the ticker DUTV, has reached an impressive milestone by receiving full payment for the first EasyFEN™ waste-to-liquid microbial fertilizer unit destined for Africa. This unit is set to be...

Continue Reading
MoonLake Immunotherapeutics Faces Lawsuit Over Stock Deception

Updated Category News Views 122

MoonLake Immunotherapeutics Faces a Serious Lawsuit Recently, MoonLake Immunotherapeutics (NASDAQ: MLTX) has come under scrutiny as a lawsuit has been filed against the company and several of its senior executives. This legal action arises from purported violations of federal securities laws, sparking concern among investors. Details of the Lawsuit The lawsuit was...

Continue Reading
Essential Tips to Reduce Your Utility Bills This Spring

Updated Category News Views 146

Essential Tips to Reduce Your Utility Bills This Spring As the warmer months approach, it's that time of year when homeowners start to notice a rise in their utility bills, particularly due to increased air conditioning usage. High 5 Plumbing, Heating, Cooling & Electric, a respected home service company, encourages residents to be proactive and identify plumbing leaks...

Continue Reading